These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 30644138)
1. Effects of sequential treatment with intermittent parathyroid hormone and zoledronic acid on particle-induced implant loosening: Evidence from a rat model. Hu B; Wu H; Shi Z; Ying Z; Zhao X; Lin T; Hong J; Wang Y; Yang Y; Cai X; Yan S J Orthop Res; 2019 Jul; 37(7):1489-1497. PubMed ID: 30644138 [TBL] [Abstract][Full Text] [Related]
2. Additive Effect of Parathyroid Hormone and Zoledronate Acid on Prevention Particle Wears-Induced Implant Loosening by Promoting Periprosthetic Bone Architecture and Strength in an Ovariectomized Rat Model. Zhou C; Wang Y; Meng J; Yao M; Xu H; Wang C; Bi F; Zhu H; Yang G; Shi M; Yan S; Wu H Front Endocrinol (Lausanne); 2022; 13():871380. PubMed ID: 35546997 [TBL] [Abstract][Full Text] [Related]
3. Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model. Bi F; Shi Z; Zhou C; Liu A; Shen Y; Yan S PLoS One; 2015; 10(10):e0139793. PubMed ID: 26441073 [TBL] [Abstract][Full Text] [Related]
4. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur. Tao ZS; Zhou WS; Qiang Z; Tu KK; Huang ZL; Xu HM; Sun T; Lv YX; Cui W; Yang L J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573 [TBL] [Abstract][Full Text] [Related]
5. Intermittent Parathyroid Hormone Enhances Cancellous Osseointegration of a Novel Murine Tibial Implant. Yang X; Ricciardi BF; Dvorzhinskiy A; Brial C; Lane Z; Bhimani S; Burket JC; Hu B; Sarkisian AM; Ross FP; van der Meulen MC; Bostrom MP J Bone Joint Surg Am; 2015 Jul; 97(13):1074-83. PubMed ID: 26135074 [TBL] [Abstract][Full Text] [Related]
6. Local delivery of a zoledronate solution improves osseointegration of titanium implants in a rat distal femur model. AbuMoussa S; Ruppert DS; Lindsay C; Dahners L; Weinhold P J Orthop Res; 2018 Dec; 36(12):3294-3298. PubMed ID: 30117189 [TBL] [Abstract][Full Text] [Related]
7. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Li YF; Li XD; Bao CY; Chen QM; Zhang H; Hu J Osteoporos Int; 2013 Mar; 24(3):1063-71. PubMed ID: 23296744 [TBL] [Abstract][Full Text] [Related]
9. Effects of alendronate on particle-induced osteolysis in a rat model. Millett PJ; Allen MJ; Bostrom MP J Bone Joint Surg Am; 2002 Feb; 84(2):236-49. PubMed ID: 11861730 [TBL] [Abstract][Full Text] [Related]
10. PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology. Bartlow CM; Oest ME; Mann KA; Zimmerman ND; Butt BB; Damron TA J Orthop Res; 2017 Aug; 35(8):1707-1715. PubMed ID: 27653318 [TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid and teriparatide have a complementary therapeutic effect on aseptic loosening in a rabbit model. Wang P; Shang GQ; Xiang S; Zhang HN; Wang YZ; Xu H BMC Musculoskelet Disord; 2021 Jun; 22(1):580. PubMed ID: 34167511 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone enhances gap healing and osseointegration in orthopedic porous coated titanium implants: a correlative micro-computed tomographic, histomorphometric and biomechanical analysis. Gao X; Meng Y; Hao D; Liu H BMC Musculoskelet Disord; 2022 Jan; 23(1):17. PubMed ID: 34980060 [TBL] [Abstract][Full Text] [Related]
13. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway. Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468 [TBL] [Abstract][Full Text] [Related]
14. Effect of combined treatment with zoledronic acid and parathyroid hormone on mouse bone callus structure and composition. Casanova M; Herelle J; Thomas M; Softley R; Schindeler A; Little D; Schneider P; Müller R Bone; 2016 Nov; 92():70-78. PubMed ID: 27542660 [TBL] [Abstract][Full Text] [Related]
16. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465 [TBL] [Abstract][Full Text] [Related]
17. Intermittent parathyroid hormone increases stability and improves osseointegration of initially unstable implants. Staats K; Sosa BR; Kuyl EV; Niu Y; Suhardi V; Turajane K; Windhager R; Greenblatt MB; Ivashkiv L; Bostrom MPG; Yang X Bone Joint Res; 2022 May; 11(5):260-269. PubMed ID: 35502760 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal Model of Periprosthetic Joint Infection in the Rat. Fan Y; Xiao Y; Sabuhi WA; Leape CP; Gil D; Grindy S; Muratoglu OK; Bedair H; Collins JE; Randolph M; Oral E J Orthop Res; 2020 May; 38(5):1101-1112. PubMed ID: 31808572 [TBL] [Abstract][Full Text] [Related]
19. Healing in peri-implant gap with BMP-2 and systemic bisphosphonate is dependent on BMP-2 dose-A canine study. Cleemann R; Sorensen M; Bechtold JE; Soballe K; Baas J J Orthop Res; 2018 May; 36(5):1406-1414. PubMed ID: 28976594 [TBL] [Abstract][Full Text] [Related]
20. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats. Tao ZS; Zhou WS; Tu KK; Huang ZL; Zhou Q; Sun T; Lv YX; Cui W; Yang L Injury; 2015 Nov; 46(11):2164-9. PubMed ID: 26404665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]